UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023225
Receipt number R000026767
Scientific Title A retrospective study of impact of excised lymph node size on lymph node metastasis and prognosis in ovarian cancer
Date of disclosure of the study information 2016/07/19
Last modified on 2018/01/23 22:16:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study of impact of excised lymph node size on lymph node metastasis and prognosis in ovarian cancer

Acronym

A retrospective study of impact of excised lymph node size on lymph node metastasis and prognosis in ovarian cancer

Scientific Title

A retrospective study of impact of excised lymph node size on lymph node metastasis and prognosis in ovarian cancer

Scientific Title:Acronym

A retrospective study of impact of excised lymph node size on lymph node metastasis and prognosis in ovarian cancer

Region

Japan


Condition

Condition

ovarian, fallopian tube, peritoneal cancer

Classification by specialty

Obstetrics and Gynecology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

1) Whether new FIGO classification for ovarian, fallopian tube, and peritoneal cancer(2014) reflect the prognosis better than FIGO classification (1988) or not. 2) Whether size of metastatic lymph nodes and size of metastatic foci of lymph nodes has correlate with prognosis or no.

Basic objectives2

Others

Basic objectives -Others

1)The correlation FIGO2014 classification for prognosis. 2)Lymph node size and metastasis. 3)Size of lymph node and foci of metastasis has correlated with prognosis or no.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1)The correlation FIGO2014 classification for prognosis.

Key secondary outcomes

2)Lymph node size and metastasis. 3)Size of lymph node and foci of metastasis has correlated with prognosis or no.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

none

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

ovarian, fallopian, peritoneal cancer

Key exclusion criteria

metastatic cancer

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshio Itani

Organization

Nara Prefecture General Medical Center

Division name

Ob & Gyn

Zip code


Address

1 30 1 Hiramatsu Nararashi Nara JAPAN

TEL

0742-46-6001

Email

yitani@nara-hp.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Itani

Organization

Nara Prefecture General Medical Center

Division name

Ob & Gyn

Zip code


Address

1 30 1Hiramatsu Nrarashi Nara JAPAN

TEL

0742-46-6001

Homepage URL

http://www.nara-hp.jp/

Email

kennara@nara-hp.jp


Sponsor or person

Institute

Nara Prefecture General Medical Center

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

none

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

奈良県総合医療センター


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 19 Day


Related information

URL releasing protocol

http://www.nara-hp.jp/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

not creected

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 06 Month 22 Day

Date of IRB


Anticipated trial start date

2016 Year 06 Month 22 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry

2017 Year 06 Month 30 Day

Date trial data considered complete

2017 Year 06 Month 30 Day

Date analysis concluded

2018 Year 12 Month 31 Day


Other

Other related information

none


Management information

Registered date

2016 Year 07 Month 19 Day

Last modified on

2018 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026767


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name